NealEvanRothschildMD

Oncology • West Palm Beach, FL

Assistant Clinical Professor of Medicine, University Fla College of Medicine

Join to view full profile

Dr. Rothschild is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rothschild's full profile

Already have an account?

Office
1309 N Flagler Dr
West Palm Beach, FL 33401
Phone+1 561-366-4100

Fax+1 561-366-4189

Education & Training

Georgetown University HospitalFellowship, Medical Oncology, 1985 - 1987
MedStar Health/Georgetown University HospitalFellowship, Hematology and Medical Oncology, 1984 - 1985
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1981 - 1984
Rutgers New Jersey Medical SchoolClass of 1981

Certifications & Licensure

FL State Medical License 1987 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
Gulfstream FL-Palm Beach Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Top Doctors: Florida Castle Connolly, 2000
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2007 Apr 01
Completed
Phase 2
A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer Start of enrollment: 2016 May 11
Completed
Phase 2

Publications & Presentations

PubMed

2 citations
Bilateral Poorly Differentiated Adenocarcinoma of the Lacrimal Gland With Tumor Regression After Treatment With Pembrolizumab.
Ann Q. Tran, Catherine J. Choi, Zakeya Mohammed Al-Sadah, Xiao Yi Zhou, Sander R. Dubovy
Ophthalmic Plastic and Reconstructive Surgery. 2020-04-09
43 citations
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma.
Patrick A. Ott, Anna C. Pavlick, Douglas B. Johnson, Lowell L. Hart, Jeffrey R. Infante
Cancer. 2019-04-01

Press Mentions

Is There a Distinct Standard of Care for “Integrative” Physicians?: The Woliner CaseOctober 13th, 2016